Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Clinical trial NCT04999969 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04999969
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2024-10-07
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.